Cell and gene therapies have been grabbing news headlines, both for their potential to cure rare diseases and for their million-dollar price tags. Milliman pharmacists and healthcare experts explain why state Medicaid agencies are particularly affected and the strategies many are using for predicting uptake and covering these high costs.
You can read the episode transcript on our website.
12/17/24 • 25 min
Critical Point - How can Medicaid pay for cell and gene therapies?
Transcript
Announcer: This podcast is intended solely for educational purposes and presents information of a general nature. It is not intended to guide or determine any specific individual situation, and persons should consult qualified professionals before taking specific action. The views expressed in this podcast are those of the speakers and not those of Milliman.
Melanie Kuester: Hello and welcome to Critical Point, brought to you by Milliman. I'm Melanie Kuester. I'm a clinical pharmacist an
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/critical-point-318345/how-can-medicaid-pay-for-cell-and-gene-therapies-80368558"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to how can medicaid pay for cell and gene therapies? on goodpods" style="width: 225px" /> </a>
Copy